Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (4): 387-390.

Previous Articles     Next Articles

Establishment of mouse model of Cytosine arabinoside-induced thrombocy-topenia

XU Guo-liang, XIAO Bing-hua1, CHEN Qi1, XU You-mei2   

  1. Jiangxi Jangzhong Pharmaceuticals Co.LTT, Nanchang330077, Jiangxi, China;
    1Department of TCM Pharmacology, Jiangxi College of TCM; 2Affliated Hospital of Jiangxi College of TCM, Nanchang330006, Jiangxi, China
  • Received:2004-12-20 Revised:2005-03-18 Online:2005-04-26 Published:2020-11-19

Abstract: AIM: To establish a mouse model of cy-tosine arabinoside (Ara-c) induced thrombocytopenia which leads inducement time more quickly and stably. METHODS: The mice were injected different dosages cytosine arabinoside (Ara-c)in two groups, respectively. The change of thrombocytopenia was observed in peripher-al hemogram and smear of marrow, andweightsof spleen, adrenal gland and thymus gland also were observed. RESULTS: The high dosage (200 mg°kg-1)to the model formation was better than low dosage (100 mg°kg-1)at inducement time and stability. The index showed no sig-nificant different between two groups except the volume of thrombocyte. CONCLUSION: Cytosine arabinoside-in-duced thrombocytopenia at high dosage (200 mg°kg-1) can induce thrombocytopenia more effectively.

Key words: cytosine arabinoside (Ara-c), animal model, thrombocytopenia, megakaryocyte, immunosup-pression

CLC Number: